Therapeutic Cytokine Development Services for Cancer Immunotherapy
Creative Biolabs' therapeutic cytokine development services deliver fully customized, next-generation biotherapeutics designed to overcome the classic cytokine paradox (high toxicity, low efficacy). We provide end-to-end rational protein engineering to create high-selectivity cytokine muteins and couple them with advanced spatial delivery platforms for tumor-confined action, which helps you overcome the cytokine paradox and achieve a superior therapeutic index.
Introduction What We Can Offer Types of Our Services Why Creative Biolabs Customer Reviews FAQs Related Services Contact Us
Introduction to Therapeutic Cytokine Development
Cytokines are highly potent, signaling proteins that govern the immune system, representing one of the most powerful tools in cancer immunotherapy. However, successful translation is repeatedly limited by the cytokine paradox: high systemic toxicity due to pleiotropy and rapid clearance from the bloodstream. Creative Biolabs' therapeutic cytokine development services for cancer immunotherapy address this by employing rational engineering to create muteins with tailored receptor specificity and by integrating advanced delivery systems to confine highly active agents directly to the disease site, thereby maximizing efficacy and safety.
For an in-depth analysis of how our services can be tailored to your specific project needs, request a consultation.
Fig.1 Cytokine engineering strategies for improving therapeutic efficacy. 1
What We Can Offer
Bespoke Rational Design and Mutein Customization
We offer a unique, tailor-made engineering service based on advanced structural modeling and bioinformatics, ensuring the creation of high-selectivity cytokine muteins perfectly aligned with your specific therapeutic target and receptor affinity requirements.
Guaranteed Treg-Sparing Technology
Our proprietary IL-2 engineering minimizes binding to the CD25 subunit, confirmed by high-resolution binding kinetics SPR/BLI, to achieve maximal CD8+ T cell and NK cell activation with negligible expansion of suppressive Treg populations.
Advanced Spatial Delivery Platform Access
Immediate access to our cutting-edge delivery systems, including pH-, Redox-, or enzyme-responsive nanoparticles and injectable hydrogels, for precise TME-confined, sustained release of highly potent cytokine payloads.
Therapeutic Cytokine Development Services at Creative Biolabs
Focus on designing Treg-sparing IL-2 variants to specifically drive the expansion and activation of CD8+ T cells and NK cells through CD25 ablation.
Specializing in complex IL-15 fusion constructs (e.g., IL-15/IL-15Rα fusions) and localized delivery for enhancing the persistence and function of CAR-T and NK cells.
Designing long-acting IL-7 conjugates and delivery systems to promote the maintenance and survival of naive and central memory T cell populations.
Engineering IL-21 muteins and immunocytokines to enhance the cytolytic activity and differentiation of T and NK effector cells.
Focus on safely delivering this highly potent, toxic agent via advanced methods like Nanoparticle encapsulation or Injectable Hydrogels for strict TME confinement.
Developing novel IL-18 variants and fusion proteins for use in Cytokine-Enhanced Cell Therapies, specifically to drive a superior, long-lived effector T cell phenotype.
Focusing on improving the PK and TME specificity of IFN-α or IFN-γ through site-specific PEGylation or antibody conjugation to maximize anti-proliferative and MHC expression effects.
Why Choose Us?
|
Key Advantages
|
Unique Features
|
|
Treg-Sparing Engineering Expertise
|
We specialize in the rational design of cytokine muteins that preferentially activate tumor-killing CD8+ T cells and NK cells while ablating the pro-suppressive expansion of Treg cells. This is the gold standard for high-potency IL-2 variants, confirmed by high-resolution receptor binding assays.
|
|
Advanced Delivery Vehicles & Spatial Control
|
Our platform includes expertise in loading high-potency, high-toxicity cytokines into pH- or Redox-responsive nanoparticles and macroscopic Injectable Hydrogels or Implanted Scaffolds. This allows for sustained release over days to weeks directly within the tumor or resection cavity.
|
|
Precision Bioconjugation
|
We utilize modern bio-orthogonal chemistry (e.g., click chemistry) for site-specific conjugation, ensuring that PK-extending moieties or targeting antibodies are attached without compromising the cytokine's receptor binding potency, leading to a cleaner, more active final product.
|
To fully understand the Creative Biolabs advantage, we invite you to get a quote today.
Customer Reviews
-
Targeted Accumulation
The application of Creative Biolabs' therapeutic cytokine development services substantially advanced our research on the development of an FAP-targeted IL-12 construct, achieving a tumor-to-systemic exposure ratio 10-fold higher than our previous efforts. - D**** M*****
-
Improved Potency
Using Creative Biolabs' therapeutic cytokine development services in our research has significantly improved the generation of an IL-7 mutein that showed superior central memory T cell persistence and proliferation in vitro compared to other published data. - S**** R*****.
FAQs
Q: How does Creative Biolabs ensure the engineered cytokine avoids systemic toxicity, especially for highly potent agents like IL-12?
A: We use a dual approach: mutein design to reduce off-target receptor affinity, and advanced delivery vehicles (nanoparticles or injectable hydrogels) to physically confine the cytokine. This ensures the agent is released slowly and locally within the tumor, preventing toxic systemic exposure.
Q: Can you help us with IL-2 development if we specifically want to avoid Treg proliferation?
A: Absolutely. Our IL-2 engineering service is centered on generating Treg-sparing variants IL-2v by introducing targeted mutations that ablate binding to the CD25 subunit. This shifts signaling preference toward CD8+ T cells, giving you a superior therapeutic window. Contact us for a detailed comparison of our IL-2v libraries versus native IL-2.
Related Services
Antibody and Protein Production
If your project requires an Immunocytokine (cytokine-antibody fusion), we offer full services for mAb discovery, humanization, and stable expression. An immunocytokine is a precisely engineered fusion protein that links the potent therapeutic activity of a cytokine directly to the high targeting specificity of a monoclonal antibody.
Learn More →
In Vivo PK Service
Comprehensive analyses encompass the precise quantification of systemic exposure, detailed tissue distribution, and measurement of immune cell fate and modulation required to definitively establish the optimal therapeutic window for translational research.
Learn More →
How to Contact Us
Creative Biolabs ensures your cytokine not only functions effectively but does so safely and exclusively within the tumor microenvironment by combining high-precision protein engineering for receptor selectivity with sophisticated bioconjugation and advanced localized delivery vehicles. Our phased, data-driven workflow is designed to accelerate your lead candidate selection and advance your most promising immunotherapy programs, please contact us.
Reference
-
Fu, Yong et al. "Engineering cytokines for cancer immunotherapy: a systematic review." Frontiers in immunology vol. 14 1218082. 6 Jul. 2023. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fimmu.2023.1218082
For Research Use Only | Not For Clinical Use
